Multi-Omics Analysis Reveals the Attenuation of the Interferon Pathway as a Driver of Chemo-Refractory Ovarian Cancer
Daria Afenteva, Rong Yu, Anna Rajavuori, Marina Salvadores, Inga-Maria P. Launonen, Kari Lavikka, Kaiyang Zhang, Anna Pirttikoski, Giovanni Marchi, Sanaz Jamalzadeh, Veli‐Matti Isoviita, Yilin Li, Giulia Micoli, Erdoğan Pekcan Erkan, Matías Marín Falco, , Sampsa Hautaniemi
The paper identifies reduced IFN-I pathway activity as a driver of chemo-refractory ovarian cancer using multi-omics analysis in a clinical trial cohort.
Cell Reports Medicine · Aug 29, 2025Peer-reviewedCancer Biology